| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.2 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |